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This thesis project was a follow-up to the Beryllium Health Surveillance Program 
(BHSP) at Rocky Flats Environmental Technology Site (RFETS) in Golden, Colorado. 
The purpose of this study was to determine the final medical outcome of additional lung 
disorders not associated with chronic beryllium disease. This information was compared to 
the radiologist report, using the International Labor Organization (ILO) classification 
system, to evaluate the effectiveness of the chest x-ray as a screening tool for pre-existing 
pulmonary function disorders. Secondly, the final medical diagnosis for each participant 
was complied into a database and compared to three databases in an effort to determine 
the incidence of pulmonary disease at RFETS.
The screening tool evaluation results indicated that if a disorder was diagnosed by 
the B-reader from the chest x-ray, the same disorder was subsequently confirmed by the 
personal physician 70 percent or more of the time for all categories except 
density/nodule/mass disorders. Specifically, chronic obstructive pulmonary disease was 
confirmed 82.8 percent of the time, restrictive pulmonary disease was confirmed 74.4 
percent of the time, and the miscellaneous diagnosis was confirmed 87 percent of the time. 
Density/nodule/mass disorders were confirmed only 35 percent of the time. Based on the 
percentage of confirmed diagnosis for each disorder the chest x-ray as diagnosed using the 
ILO classification system by a certified B-reader appears to be a good screening tool, if a 
70 percent or less accuracy is required, for chronic obstructive pulmonary disease, 
restrictive pulmonary disease, and miscellaneous disorders. The ILO classification system 
was not effective in identifying and diagnosing density/nodule/mass disorders that may be 
indications of potential lung cancer.
iii
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When confidence intervals were calculated it was confirmed that the overall 
effectiveness of the chest x-ray is an adequate screening tool for the specific lung disorders 
in this study except the density/nodule/mass disorder. The chi-square test determined that 
agreement between the diagnosis of the radiologist and the participant’s personal physician 
is highly dependent on the specific lung disorder.
The second part of this thesis was to determine if the incidence of lung disorders at 
RFETS was less than the incidence in the State of Colorado. Unfortunately, database 
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People are exposed on and off the job to a variety of hazardous substances. Most 
of these substances do not present a hazard under ordinary circumstances, but they all 
have the potential for being injurious depending on the concentration, the route of 
exposure, and the duration of the exposure. This concept has been recognized since the 
time of Paracelsus (1493 - 1541) when he stated that "All substances are poisons; there is 
none which is not a poison. The right dose differentiates a poison from a remedy (Amdur 
and others, 1993)."
Four routes exist as possibilities of hazardous substance exposure (1) ingestion, (2) 
skin absorption, (3) injection (i.e., penetrating wound, needle prick, etc.), and (4) 
inhalation. Of these four modes of entry, inhalation is considered in this thesis. Inhalation 
is important because of the rapidity with which a hazardous substance can be absorbed in 
the lungs, pass into the bloodstream, or cause damage to the delicate tissue of the lungs. 
Nearly all materials that are airborne can be inhaled. Frequently, pulmonary diseases are 
irreversible or fatal because of the delicate tissue structure of the lungs. Currently, 
nonspecific pulmonary diseases are considered the major occupational health hazard in the 
United States (Saric, 1992).
Occupational pulmonary diseases are a preventable source of morbidity and 
mortality. A significant number of chronic obstructive pulmonary diseases and
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pneumoconioses are caused by well-established agents and reducing the incidence of these 
diseases is an important and achievable goal (Markowitz, 1992). Table 1 (Markowitz, 
1992) lists some common agents and the impairment associated with the resulting disease. 
It has been estimated that 15 percent of lung cancer in men and 5 percent in women can be 
attributed to occupational exposures (Coultas and Samet, 1992). Prevention of these 
diseases requires recognition, evaluation, and control of workplace hazards. Currently, 
these diseases are recognized but more evaluation is necessary to adequately assess the 
controls. If workplace respiratory exposures are lowered, it can be assumed that, this will 
reduce the overall occurrence of work-related pulmonary disorders.
1.1 Background
The focus of this thesis is on the Beryllium Health Surveillance Program (BHSP) 
at Rocky Flats Environmental Technology Site (RFETS) in Golden, Colorado. EG&G 
Rocky Flats, Inc., initiated the program as a health surveillance tool for retired, former, 
current Rocky Flats' employees, subcontractors, and Department of Energy (DOE) 
employees. It is a voluntary program that is currently funded by DOE. During the course 
of the BHSP it was determined that there was a significant portion of the study population 
that had potentially been exposed to occupational hazards other than beryllium.
This thesis project is a follow-up to the BHSP to determine the final medical 
outcome of those additional lung disorders not associated with chronic beryllium disease. 
The final medical outcome is important to the study to determine how accurate the chest 
x-rays are in determining a pre-existing lung disorder that may result in the employee 
being more susceptible to a workplace exposure. Beryllium is a good example of certain 
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Beryllium can cause an allergic-like reaction in certain people with a predisposition for 
beryllium sensitivity. This is why prescreening in the workplace is so important in jobs 
that may require some type of exposure.
The BHSP is currently being conducted at the RFETS which was established in 
1952 on a site 16 miles northwest of downtown Denver in Jefferson County. The plant 
site occupies 11 square miles, including a 384-acre production facility surrounded by an 
undeveloped preserve that serves as a buffer area. For almost 40 years, RFETS had two 
main missions. The first was the production of "triggers" for nuclear weapons. The 
plutonium triggers, also known as pits, are the first stage fission bombs used to set off the 
second-stage fusion reaction of a hydrogen bomb. The second mission was processing of 
retired weapons for plutonium recovery. This process required dismantling the 
components it originally produced to retrieve and recycle the materials of value 
(ChemRisk, 1992). Today, RFETS has an environmental cleanup mission and no longer 
produces any parts for nuclear weapons.
Beryllium was used in the research and development process of weapon parts 
starting in 1953. Early process operations involved pressed-powder beryllium which had 
been cut in the shape of a bowl. These bowls were heat-treated and then machined to the 
required dimensions in Building 444. Beryllium became part of the primary production 
line in 1958, at which point the plant began casting its own beryllium ingots. The ingots 
were cut up into puck-like billets, then heated and rolled to the desired thickness 
(ChemRisk, 1992).
Early beryllium machining operations were not enclosed. Local exhaust, "elephant 
trunks", were used for ventilation near beryllium machines and open hoods. Originally,
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the "elephant trunks" were cyclone separator units placed at each machine to filter the air 
at the point of operation. In 1974, the cyclone separator units were taken out of service 
and replaced by an overhead duct system. The overhead duct system was an external chip 
cyclone with a HEPA filtration unit. The last ventilation upgrade was in 1986. The 
HEP A filtration units were upgraded with one additional stage of HEPA filtration. The 
new system included two types of conveyance systems, a low vacuum local exhaust 
system to carry the fine particulates and a high vacuum local exhaust to carry the heavier 
particulates. Each subsystem had its own cyclone separator, which was then connected to 
its own HEPA filtration unit (ChemRisk, 1992).
The BHSP was initiated to detect possible long term health effects of beryllium to 
people who have worked at RFETS. Inhalation of beryllium dust and fumes is the most 
common cause of beryllium poisoning (Eisenbud and Lisson 1983). The effects of 
inhaling high levels of beryllium can range from mild inflammation of pulmonary 
membranes to a severe pneumonia reaction. Sometimes a metallic taste also may signal 
beryllium poisoning. An allergic-like recurrence of these symptoms may show up later, 
after exposure to much lower levels of beryllium. Chronic beryllium disease may not show 
up for 20 years after the last exposure to beryllium. Chronic beryllium disease is 
characterized by granulomas in the lungs. Symptoms are characterized by coughing, 
difficulty in breathing, chest pain and tightness, general weakness, and tiredness. 
Pulmonary dysfunction and systemic effects, such as heart enlargement, enlargements of 
the liver and spleen, cyanosis, and the appearance of kidney stones are also characteristic 
of chronic beryllium disease (Plog, 1988).
The RFETS BHSP began in June of 1991. The program provided health 
surveillance testing for all employees who believed they may have been exposed to
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beryllium while employed at RFETS. Three techniques were utilized to identify 
participants who were potentially exposed to beryllium: 1) a lymphocyte proliferation test 
was used to detect beryllium sensitization, 2) posterior and anterior chest x-rays were 
taken and evaluated by board certified radiologists who were certified B-readers according 
to the International Labor Organization (ILO) classification system for radiographs of 
pneumoconioses. The ILO classification is a standardized internationally accepted system 
that identifies radiographic changes of lung disorders and provides a means of comparison 
between chest x-rays (Potchen and others, 1993), and 3) medical evaluations were 
conducted at two major medical centers with experience in the diagnosis of chronic 
beryllium disease.
The Medical Director at EG&G Rocky Flats received information provided by the 
certified ILO classification system B-reader radiologist and then proceeded to divide the 
chest x-rays into three groups specifically for the purpose of the RFETS study: 1) 
Category "A" chest x-rays were considered to be normal, meaning that no lung 
abnormalities were noted by the certified B-reader using the ILO classification system; 2) 
Category "B" chest x-rays were considered abnormal chest x-rays, meaning that the B- 
reader noted an abnormality that was not associated with chronic beryllium disease; and 3) 
Category "C" chest x-rays were considered as a probable diagnosis of chronic beryllium 
disease..
All participants with a category "B" chest x-ray were notified by the EG&G 
Medical Director of the findings, provided a copy of the B-reader chest x-ray report, and 
advised to seek medical assistance from their personal physicians. Current employees who 
received a Category "B" chest X-ray report also met with a RFETS Occupational Health 
Physician regarding their findings, and were referred to their personal physicians if
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appropriate. This thesis study was initiated by EG&G Rocky Flats to determine the 
medical outcome in relation to information found on those Category "B" chest x-rays.
1.2 Purpose and Scope
This thesis study was a follow-up to the RFETS's original Beryllium Health 
Surveillance Program. The purpose was to determine a final medical diagnosis, from each 
participant’s personal physician, for each abnormal (Category "B") chest x-ray not related 
to chronic beryllium disease. The scope of this study was to first determine the final 
medical diagnosis from each participant's personal physician. This information was then 
compared to the radiologist report to evaluate the effectiveness of the chest x-ray as a 
screening tool for pre-existing pulmonary function disorders. Secondly, the final medical 
diagnosis for each participant was complied into a database. This database was evaluated 
and compared to three other databases in an effort to determine the incidence of 
pulmonary disease at RFETS. The databases used were the following: 1) Colorado 
Division of Workers' Compensation Lost Time Claims for Obstructive Pulmonary Disease 
(Rohrback, 1994), 2) Colorado Division of Workers' Compensation Lost Time Claims 
for Restrictive Pulmonary Disease (Rohrback, 1994), and 3) Colorado Central Cancer 
Registry (Karp and others, 1991).
1.3 Hypothesis
The two-part hypothesis statement of this study is as follows: 1) The chest x-ray 
is a good screening tool for detection of pulmonary function disorders in the workplace, 
and 2) The abnormal chest x-rays incidence rate in this study will be less than the
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occurrence of abnormal chest x-rays from lung disorders (e.g., chronic obstructive 
pulmonary disease, asbestosis, silicosis, lung cancer, etc.), when compared to available 
databases.
The author formulated the second part of the hypothesis based on the idea that a 
large number of the population in this study were laborers and were probably in better 




The following methodology was used to conduct this thesis study:
1) All abnormal chest x-rays (Category “B”), from the BHSP, taken between 
October 1991 and January 1993 were used as the study population. An 
abnormal chest x-ray was defined as a chest x-ray that did not show any 
evidence of chronic beryllium disease and was not considered normal as 
evaluated by a certified B-reader based on the ILO classification system.
The ILO classification system determines chronic beryllium disease by 
radiographic features, which include granular (up to 1mm in diameter), 
nodules (1 mm to 5 mm in diameter), and linear features specific to chronic 
beryllium disease. A normal chest x-ray is determined by the absence of 
any radiographic abnormalities. Figure B-l is a sample of the form the B- 
reader used to document the findings of the chest x-ray.
2) The database for the study was then developed with the categories of 
interest to RFETS. The categories included: study number, age, sex, chest 
x-ray date, date the chest x-ray was read by the B-reader, if the participant 
was a smoker or nonsmoker, chronic obstructive pulmonary disease, 
restrictive pulmonary disease, nodule/density/mass determination, and
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miscellaneous disorders. The personal identification information (i.e., age, 
sex, chest x-ray date, smoker information, etc.) was taken from a 
questionnaire that the participant filled out as part of the BHSP.
3) Each participant in the BHSP who was determined to have an abnormal 
chest x-ray (Category “B”) for that period was sent a letter (Figure B-2) 
from F.J. Furman, M.D., Medical Director (EG&G Rocky Flats), a release 
of information form (Figure B-3), and a letter from the United 
Steelworkers of America (Figure B-4). The letter from Dr, Furman was an 
explanation of the follow-up study and a request to participate in the 
program. The release of information form specifically asked for the 
information regarding the participant's chest x-ray, with atypical results, 
that was taken as part of the BHSP. The United Steelworkers of America 
is the primary union at RFETS and their letter encouraged all BHSP 
participants with atypical chest x-ray findings to participate in the follow- 
up study.
4) All participants who sent back the release of information form were first 
entered into the database and then contacted by telephone. The interviewer 
asked if they had contacted their personal physicians concerning the final 
medical diagnosis of their abnormal chest x-rays as determined by the B- 
reader during the BHSP. If the participants contacted their personal 
physician and were aware of the final medical diagnosis, this information 
was recorded. Personal physicians were contacted only when the 
participants did not know or were unsure of their medical diagnoses as they 
related to the specific chest x-rays taken for the BHSP.
All the information obtained from the telephone interviews was entered 
into the database. The database was used to determine percent response to 
the survey, total participants with a final medical diagnosis, and total 
participants with a correct final diagnosis versus an incorrect final 
diagnosis. Distribution by age and lung disorder was completed for each 
participant with a correct diagnosis.
A search was also conducted to find appropriate databases for comparison. 
This was done through literature searches in the major Colorado university 
libraries, telephone interviews with the Colorado Division of Workers' 
Compensation, Colorado Department of Health, and the Colorado Central 
Cancer Registry.
Once the data were evaluated, the first hypothesis was tested by assessing 
the effectiveness of the ILO classification system as a pre-screening tool for 
lung disorders in the workplace. The first hypothesis was tested through a 
percentage response by lung disorder, confidence interval calculation and 
then by a chi-square test for an overall assessment of effectiveness for all of 
the disorders. The second hypothesis was tested by assessing the database 
against existing databases. This was an attempt to determine an incident 




The following sections provide a brief overview of the technical background 
necessary for this study.
3.1 Pulmonary System
The pulmonaiy system is composed of two main areas: 1) the upper respiratory 
tract airways - the nose, throat, trachea, and major bronchial tubes leading to the lungs; 
and 2) the alveoli where the actual transfer of gases across thin cell walls takes place. Air 
first enters the respiratory system through the nose or mouth. Air then passes through the 
glottis and the larynx and enters the tracheobronchial tree (Gray, 1977). After passing 
through the conducting airway, the inspired air enters the alveoli, where it comes into 
contact with the pulmonaiy capillaries. The pulmonary capillaries are responsible for the 
rapid exchange of oxygen and carbon dioxide between the atmosphere and the blood 
(Levitzky, 1991).
The vital capacity of the lungs range from about 0.5 liters at rest to 3.3 liters at 
deepest inspiration. During an 8-hour day a person breathes about 8500 liters of air 
(Thibodeau and others, 1992), with approximately 10,000 liters of air inspired into the 
lungs every day (Levitzky, 1991). The inspired air may contain dust, pollen, ash, bacteria, 
or hazardous chemicals all of which could damage the delicate lung tissues. Particles
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smaller than about 5 micrometers in diameter are the most likely to enter the deeper lung 
or the alveolar sac and not be exhausted from the lungs (Fishman 1992). The following 
sections briefly describe lung disorders that were identified in this study.
3.2 Lung Disorders
The abnormal chest x-rays in this study were separated into four categories:
1) chronic obstructive pulmonary diseases, 2) restrictive pulmonary diseases, 3) 
density/nodule/mass (potential lung cancer), and 4) miscellaneous disorders (broken ribs, 
surgery, etc.). These four categories are described below.
3.2.1 Chronic Obstructive Pulmonary Diseases
Chronic obstructive pulmonary disease (COPD) is often used to describe 
conditions of people who have emphysema, bronchial asthma, or a mixture of the two. 
COPD is the progressive, irreversible obstruction of the airways. Occupational asthma is 
generally defined as variable air flow limitation caused by a specific agent in the workplace 
(Alberts and Brooks, 1992). Emphysema is a lung disorder characterized by trapping of 
air in alveoli of the lung that causes them to rupture and fuse to other alveoli (Thibodeau 
and others, 1992). People with COPD have difficulty breathing, especially during 
expiration.
COPD afreets approximately 14 million people in the United States. Of these 14 
million, 12 million have bronchial asthma and 2 million have emphysema. COPD is 
currently the fifth leading cause of death in the United States (Owens, 1991). The overall 
prevalence of occupational asthma is not known but has been estimated to represent 2
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percent of all asthmatics. In Japan, it is estimated that 15 percent of the asthma in men is 
due to occupational exposure (Alberts and Brooks, 1992).
A number of different conditions may cause obstruction of the airways. Cigarette 
smoke is the most common air pollutant that can trigger a constriction of bronchial 
airways. In obstructive disorders, the total lung capacity may be normal, but the time it 
takes to inhale or exhale maximally is significantly increased (Thibodeau and Patton,
1992).
Emphysema may result from the progression of chronic bronchitis or other 
conditions as air becomes trapped within alveoli and causes them to become abnormal and 
much larger than normal. As the alveoli enlarge, their walls rupture and reduce the total 
surface area of the lung, making breathing difficult.
Asthma is an obstructive disorder characterized by recurring spasms of the smooth 
muscle in the walls of the bronchial air passages. The muscle contractions narrow 
airways, making breathing difficult. Inflammation (edema and excessive mucus 
production) usually accompany the spasms, further obstructing the airways.
3.2.2 Restrictive Pulmonary Diseases
Restrictive pulmonary diseases involve restriction of the alveoli. Restrictive 
pulmonary disease differs from obstructive pulmonary disease because it inhibits 
inspiration, and reduces pulmonary volumes and capacities. Restrictive pulmonary disease 
results from an inflammation or fibrosis (scarring) of lung tissue caused by exposure to 
asbestos, coal, silica, or dust (Schwarz and King, 1993).
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Pneumoconiosis is a term that describes various pulmonary diseases of dust 
inhalation exposure that result in restrictive pulmonary diseases (NIOSH, 1977). The 
typical pathological condition in pneumoconiosis is the production of fibrotic tissue in the 
alveolar sacs. The fibrotic tissue reduces the efficiency of the lungs by making them less 
resilient, and by reducing the effective working surface for gaseous exchange.
Asbestosis is probably the most common pneumoconiosis, caused by the inhalation 
of asbestos fibers. Asbestosis is a diffuse, interstitial, nonmalignant scarring of the lungs. 
Pleural findings include fibrotic scar tissue also called plaques, calcified plaques, diffuse 
thickening, and mesothelioma. The severity of asbestosis is related to the type of asbestos, 
the duration of exposure, the amount of exposure, and when the person was first exposed. 
Radiographically, small linear irregular plaques are located usually on the lower lateral 
chest wall and on the central portion of the diaphragm. Less than 5 percent of plaques 
occur in subjects with less than 20 years exposure (Baum and Wolinsky, 1989).
Generally, a large cumulative exposure is necessary for the development of asbestosis.
The latency of the disease is approximately 20 years, but may be as early as 15 years in 
highly exposed workers (Epler, 1992).
Coal workers' pneumoconiosis (CWP), miners' black lung, is associated with 
chronic overexposure to coal dust. Varying degrees of fibrotic changes and symptoms can 
occur with CWP. It can develop from simple fibrosis to progressive massive fibrosis and 
result in a severe restriction of lung capacity (Parkes, 1982). CWP has declined during the 
past 50 years due to the control of coal dust in mines. The current prevalence rate in 
working miners is approximately 10 percent, which is a marked improvement from 75 
percent in retired miners (Epler, 1992).
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Silicosis is classified as a lung disease caused by the inhalation of free silica dust. 
This disease develops because silica is toxic to lung macrophage cells. The most common 
criteria used in diagnosing silicosis are the results obtained from pulmonary function tests, 
chest x-rays, and occupational exposure histories. A chest x-ray is a moderately good 
indicator of the degree to which tissue reacts to exposure of free silica. Unfortunately, a 
silicosis chest x-ray is very similar to other pneumoconioses. In the United States the 
occurrence of silicosis has declined significantly. Occasionally, isolated acute cases are 
reported, usually related either to some unusual household situation, such as inhalation of 
domestic scouring powder, or to ignoring or not taking effective preventive measures in 
the workplace as regulated by the government (Epler, 1992).
3.2.3 Density/Nodule/Mass
A density/nodule/mass description on a chest x-ray is generally considered a 
potential indication of lung cancer. This study was focussed on the confirmation of only a 
density/nodule/mass description, as described by the B-reader, and did not determine if the 
study participant had a confirmed case of lung cancer.
Lung cancer, once a rare disease, is now one of the leading causes of death in the 
United States. The most common predisposing conditions associated with lung cancer are 
cigarette smoking and exposure to "second-hand" cigarette smoke. The risk of lung 
cancer, from an occupational exposure, for current smokers is increased approximately 20 
times and for former smokers the risk is 10 times that of a nonsmoker (Coultas and Samet, 
1992).
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Lung cancer is a malignancy of pulmonary tissue that not only destroys the gas- 
exchange tissues of the lungs but like other cancers may also invade other parts of the 
body. Lung cancer most often develops in damaged or diseased lungs (Pare, 1983).
Associations of specific occupations with excess lung cancer risk were well 
recognized even before the epidemic of lung cancer caused by smoking was identified 
during the 1950s. Agricola, in the 1500s, documented the high incidence of fatal 
pulmonary disease in underground miners from dusty conditions and gaseous emissions.
In the late 1800s, Harting and Hesse showed that these miners developed respiratory 
malignancy, and then in 1913 Amstein reported the malignancy as lung cancer (Coultas 
and Samet, 1992). Other case histories reported in the early 1900s indicated that workers 
exposed to arsenic, asbestos, chromium, nickel, and coal combustion products were at an 
increased risk for lung cancer (Pare, 1983).
3.2.4 Miscellaneous Disorders
Participants in this category had a number of conditions, such as, broken ribs, 
enlarged heart, scars from chest surgery, bullet wounds, and partial lung removal. These 
conditions were not considered individually because they are not directly related to an 
occupational exposure.
3.3 Chest Radiography
Lung diseases are generally diagnosed by a physical examination, pulmonary 
function test, exposure history, and a chest x-ray. A chest x-ray is important in the 
detection, differential diagnosis, and monitoring of lung disorders. The chest x-ray in
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many cases provides the only objective evidence that a pulmonary disorder is present when 
symptoms of abnormality are minimal or absent (Newell and Tarver, 1993).
The chest x-rays in the Beryllium Health Effects Study were evaluated based on 
the ILO classification. This system was originally developed in 1930 to describe 
pneumoconiosis in coal miners (NIOSH, 1977). The ILO classification provides a simple 
reproducible means of systematically recording changes in the lung associated with the 
inhalation of dusts. The ILO classification provides two pieces of information, 
categorization of the size or form of opacities and an indication of their profusion or 
extent in the lung fields. It is most useful in relating the radiographic features to dust 
exposures and changes in lung function (Weill and Tumer-Warwick, 1981).
A set of standard chest x-rays is used for this classification. These chest x-ray 
films provide examples of abnormalities and show differing levels of profusion of small 
opacities. Standard chest x-rays are also included for such features as pleural thickening 
and cardiac abnormalities (Parkes, 1982). The chest x-rays in the BHSP were compared 
to the standard chest x-ray films by a National Institute of Occupational Safety and Health 
(NIOSH) certified B-reader.
Basically the ILO classification system identifies the radiographic features by small 
(less than 1 centimeter) and large (greater than 1 centimeter) opacities. Therefore, simple 
pneumoconiosis is diagnosed when none of the opacities exceeds 1 centimeter in diameter, 
and a complicated pneumoconiosis is diagnosed when one or more of the opacities exceed 
1 centimeter in diameter. The small opacity category is further characterized by the type, 
profusion, and extent (NIOSH, 1977).
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The latest version of the ILO classification system was published in 1980 (Graham, 
1992). The system first requires the B-reader to determine if the chest x-ray film is normal 
or abnormal. If the chest x-ray film is abnormal, then the B-reader determines if the 
abnormalities are consistent with pneumoconiosis. Next the B-reader rates the chest x-ray 
film as to the primary and secondary size and shape of the opacities, their locations within 
six different lung zones, and the profusion, which indicates the density of changes. The 
two types of opacities are either rounded, designated p, q, and r, depending on the size, or 
irregular, designated s, t, and u. The ILO classification system also requires an evaluation 
as to whether large opacities are present and an estimation of the extent. Pleural changes 
are graded as to thickness, extent, and whether or not the pleura are calcified. Finally, 
there are 22 designations that allow the B-reader to indicate other diseases that may be 
present, such as potential lung cancer (density/nodule/mass), heart disease, and 
emphysema.
Figure B-l is an example of the form filled out by the B-reader during the 
evaluation of the chest x-ray. Tables 2 through 4 are definitions of the terms used in the 
ILO classification (Sperber, 1990).
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Table 2





P diameter up to about 1.5 mm
q diameter exceeding about 1.5 mm and 
up to about 3 mm
r diameter exceeding about 3 mm and 
up to about 10 mm
s width up to about 1.5 mm
t width exceeding 1.5 mm and up to 
about 3 mm
u width exceeding 3 mm and up 
to about 10 mm
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Table 3
ILO Classification of Pleural Thickening
and Calcification
Pleural Thickening Pleural Calcification
Width: On the lateral chest wall, the measurement 
of the maximum width of the shadow is made from 
the inner line of the chest wall to the inner margin 
of the shadow seen most sharply at the 
parenchymal-pleural boundary.
a = maximum width up to about 5 mm 
b = maximum width over about 5 mm and 
up to about 10 mm
c = maximum width over about 10 mm
If pleural thickening can be seen face on, this 
should be recorded, even if it can also be seen in 
profile. Pleural thickening that can only be seen 
face on generally has no measurable width.
Extent: This means maximum length, or sum of 
maximum lengths either in profile or face on.
1 = total length equivalent to up to one 
quarter of the projection of the lateral 
chest wall
2 = total length exceeding one quarter but 
not one half of the projection of the lateral 
chest wall
3 = total length exceeding one half of the 
pro jection of the lateral chest wall
Site and extent are recorded for each lung 
separately.
1 = an area of calcified pleura with greatest 
diameter up to about 20 mm, or a number of such 
areas the sum of whose greatest diameters does not 
exceed about 20 mm.
2 = an area of calcified pleura with greatest 
diameter exceeding about 20 mm and up to about 
100 mm, or a number of such areas the sum of 
whose greatest diameters exceeds about 20 mm but 
does not exceed about 100 mm.
3 = an area of calcified pleura with greatest 
diameter exceeding about 100 mm, or a number of 




Symbols for the ILO Classification Comments
ILO Classification Symbol Symbol Definition
ax coalescence of small opacities
bu bulla(e)
ca cancer of lung of pleura
cn calcification in small opacities
C O abnormal cardiac size or shape
cp cor pulmonale
cv cavity
di marked distortion of intrathoracic organs
ef effusion
em definite emphysema
es eggshell calcification of lymph nodes
fr fractured rib(s)
hi enlargement of hilar or other nodes
ho honeycomb lung
id ill-defined diaphragm
ih ill-defined heart outline
kl septal (Kerley) lines
od other significant abnormality
Pi pleural thickening in the interlobular fissure or mediastinum
px pneumothorax
r p rheumatoid pneumoconiosis




A total o f2,097 chest x-rays were taken, as part of the BHSP, between October 
1991 and January 1993. Of these 2,097 chest x-rays 337 males and 30 females were 
identified with abnormal chest x-rays (Category "B") not associated with chronic beryllium 
disease.
Letters were sent to the 367 participants and response was received from 340 
participants, 93 percent of the total. Table A-l contains a summary of the responses 
found in this study which are as follows: 35 percent of the population received a final 
medical diagnosis from their personal physician, 25 percent of the abnormal chest x-rays 
were considered normal by the participant’s personal physician, 17 percent of the 
participants never communicated with their personal physicians concerning the abnormal 
chest x-ray, 2 percent of the population was deceased, 14 percent of the population listed 
no forwarding address, and 7 percent of the population had no response at all.
The total population that received a final medical diagnosis was 220. Of the 220 
participants, agreement between the diagnosis of the radiologist and the participant’s 
personal physician was observed in 58 percent of the population and disagreement was 
observed in 42 percent of the population. Table A-2 describes the 220 participants with a 
final medical diagnosis, both those which agreed and those which disagreed with the 
finding of the radiologist. Table A-3 lists the 220 participants with a final medical
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diagnosis, that both the radiologist and the participant’s personal physician agreed upon, 
distributed by age. Table A-4 includes those participants with a confirmed final 
diagnosis distributed by age. Tables A-5 through A-8 are participants with a final 
diagnosis, that both the radiologist and personal physician agreed on, distributed by age 
and condition, i.e., chronic obstructive pulmonary disease, restrictive pulmonary disease, 
density/nodule/mass, and miscellaneous disorders.
Figure 1 is a graphical representation of the confirmed versus unconfirmed 
diagnosis for chronic obstructive pulmonary disease, restrictive pulmonary disease, 
density/nodule/mass disorder, and miscellaneous disorders. As can be seen in Figure 1, 
the certified B-reader using the ILO classification was most accurate in diagnosing chronic 
obstructive pulmonary disease (24 correct versus 5 not incorrect), restrictive pulmonary 
disease (32 correct versus 11 incorrect), and miscellaneous disorders (80 correct versus 12 
incorrect). The density/nodule/mass disorder has a correct diagnosis confirmed only 37 
times versus an incorrect diagnosis 67 times. Figure 2 also represents the confirmed 















Graphical Representation of Confirmed Versus Unconfirmed Diagnosis 
by Number of Participants and Lung Disorder
C O PD RPD D/N/M
Lung D isorders
Misc.
Confirmed Diagnosis U nconfirm ed D iagnosis
Figure 1 Acronym Definitions
COPD - Chronic Obstructive Pulmonary Disease 
RPD - Restrictive Pulmonary Disease 




Graphical Representation of Confirmed Versus Unconfirmed Diagnosis 
by Percent Diagnoses and Lung Disorder
COPD RPD D/N/M Misc.
Lung Disorders
H  Confirmed Diagnosis Q  Unconfirmed Diagnosis
Figure 2 Acronym Definitions
COPD - Chronic Obstructive Pulmonary Disease 
RPD - Restrictive Pulmonary Disease 





The first hypothesis of this thesis is that the chest x-ray is a good screening tool for 
the detection of pulmonary function disorders in the workplace. This was evaluated by 
confirming the B-readers diagnosis with the participant's personal physician's diagnosis. 
Tables 7 through 10 present a summary of the results for each disorder, i.e., chronic 
obstructive pulmonary disease, restrictive pulmonary disease, density/nodule/mass 
disorders, and miscellaneous. This evaluation included the 220 participants who had a 
follow-up examination with their personal physician as a result of their abnormal chest x- 
ray from the BHSP.
5.1 Database Results
Results indicate that if a disorder was diagnosed by the B-reader from the chest x- 
ray, the same disorder was subsequently confirmed by the personal physician 70 percent or 
more of the time for all categories except density/nodule/mass disorders. Specifically, 
chronic obstructive pulmonary disease was confirmed 82 .8 percent of the time, restrictive 
pulmonary disease was confirmed 74.4 percent of the time, and the miscellaneous 
diagnosis was confirmed 87 percent of the time. Density/nodule/mass disorders were 
confirmed only 35 percent of the time. In general, the interviewer observed that a final 
medical diagnosis was received from the participant's personal physician within 
approximately one year of the initial notification from the medical director at Rocky
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Flats. Based on the percentage of confirmed diagnosis for each disorder the chest x-ray as 
diagnosed using the ILO classification system by a certified B-reader appears to be a good 
screening tool for chronic obstructive pulmonary disease, restrictive pulmonary disease, 
and miscellaneous disorders. The ILO classification system was not effective in 
identifying and diagnosing density/nodule/mass disorders that may be indications of 
potential lung cancer.
Table 5
Verification of Diagnosed 




















20-29 1 0 0 0 0 0
30-39 7 1 1 100 0 0
40-49 28 0 0 0 0 0
50-59 38 1 1 100 0 0
60-69 76 14 11 78.6 3 21.4
70-79 64 13 11 84.6 2 15.4
80-89 6 0 0 0 0 0
Totals 220 29 24 82.8 5 17.2
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Table 6 





















20-29 1 0 0 0 0 0
30-39 7 0 0 0 0 0
40-49 28 5 3 60 2 40
50-59 38 7 5 71.4 2 28.6
60-69 76 13 10 76.9 3 23.1
70-79 64 16 12 75 4 25
80-89 6 2 2 100 0 0
Totals 220 43 32 74.4 11 25.6
Table 7




















20-29 1 1 0 0 1 100
30-39 7 5 2 40 3 60
40-49 28 16 3 18.8 13 81.2
50-59 38 21 6 28.6 15 71.4
60-69 76 39 16 41 23 59
70-79 64 21 10 47.6 11 52.4
80-89 6 1 0 0 1 100
Totals 220 104 37 35.6 67 64.4
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Table 8





















20-29 1 0 0 0 0 0
30-39 7 1 1 100 0 0
40-49 28 8 7 87.5 1 12.5
50-59 38 16 13 81.2 3 18.8
60-69 76 34 34 100 0 0
70-79 64 28 21 75 7 25
80-89 6 5 4 80 1 20
Totals 220 92 80 87 12 13
Table 9
Verification of Diagnosed 
All Four Lung Disorders
















29 24 82.8 5 17.2
Restrictive 
Pulmonary Disease
43 32 74.4 11 25.6
Density/Nodule/Mass 104 37 35.6 67 64.4
Miscellaneous 92 80 87 12 13
Totals 268 173 64.6 95 35.4
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5.2 Statistical Evaluation
As can be seen from the data, based on percentages for each lung disorder, the 
chest x-ray appears to be a good screening tool when comparing specific disorders, if a 70 
percent or less accuracy is required. In an attempt to evaluate the chest x-ray as a 
screening tool in general for the four disorders in this study, confidence intervals were 
calculated for the confirmed diagnoses of each lung disorder and a chi-square (X2) test 
was used for evaluation of the relationship between a confirmed and unconfirmed 
diagnosis (Munro and others, 1986).
Confidence intervals are used to determine the confidence that a population of 
values falls within certain boundaries. The following calculations are an estimate that 
given a certain mean for all four lung disorders that the population of values will fall 
between the established boundaries.
Table 10
Standard Deviation of Four Lung Disorders






Chronic Obstructive Pulmonary Disease 29 0.828 0.070
Restrictive Pulmonary Disease 43 0.744 0.067
Density/Nodule/Mass 104 0.356 0.047
Miscellaneous 92 0.870 0.035
Total 268 0.646 0.029
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(1) N is a symbol for the number of participants in the population.
(2) p is the percentage of confirmed diagnoses and was calculated as follows:
p = number of confirmed diagnoses
number of total diagnosed with disorder
(3) a  is the standard deviation and is a measure of variability. The standard 
deviation represents the average amount by which results vary from the 
central tendency or mean.
q2 = e(i-e)
N
(4) 95 percentile confidence intervals for the percentage of confirmed
diagnoses were calculated as follows for each lung disorder and for all of 
the lung disorders:
95% = p ± 1.96(o)
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Chronic Obstructive Pulmonary Disease
95% = 0.828 ± (1.96)(0.070) 
95% = 0.828 ± 0.137 
0.691 £ 0.828 <; 0.965
Restrictive Pulmonary Disease
95% = 0.744 ± (1.96)(0.067) 
95% = 0.744 ±0.131 
0.613 <; 0.744 <; 0.875
Density/Nodule/Mass Disorders
95% = 0.356 ± (1.96)(0.047) 
95% = 0.356 ±0.092 
0.264 <; 0.356 <; 0.448
Miscellaneous Disorders
95% = 0.870 ± (1.96)(0.035) 
95% = 0.870 ± 0.069 
0.801  ̂ 0.870  ̂0.939
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All Lung Disorders
95% = 0.646 ± (1.96)(0.029)
95% * 0.646 ± 0.057 
0.589 <; 0.646 s 0.703
The 95 percentile confidence interval calculation confirmed the original conclusion 
that the chest x-ray is a good screening tool for all of the lung disorders (i.e., chronic 
obstructive pulmonary disease, restrictive pulmonary disease, and miscellaneous disorders) 
except the density/nodule/mass disorders.
The chi-square test is used to evaluate the relationship between the expected 
number of people that fall into a category and the actual, or observed number of people 
that fall into a category. The idea of the chi-square test is that the null hypothesis is true, 
if the observed frequencies do not deviate too much from their expected values.
The null hypothesis for this evaluation is the following: A diagnosis that both the 
radiologist and participant's personal physician agree upon is independent of the type of 
lung disorder in this study, i.e., chronic obstructive pulmonary disease, restrictive 















Restrictive Pulmonary Disease 32 11 43
Density/Nodule/Mass 37 67 104
Miscellaneous Disorders 80 12 92
TOTAL 173 95 268
(5) The expected frequency for the chi-square analysis is calculated using the 
observed frequency with the following equation, where:
fo = observed frequency (values listed above in Table 11)
df = degrees of freedom 
(columns - l)(rows-l)
( 2 - l ) ( 4 - l )  = 3
fe = expected frequency (values calculated below)
fe — fo (observed frequency of the lung disorder) x fo (observed frequency 
of the diagnosis) / Total Population
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(6) Chronic Obstructive Pulmonary Disease Expected Value Calculation
fe = (29 x 173)/268 = 18.72 (expected frequency with a confirmed
diagnosis of chronic obstructive 
pulmonaty disease)
fe = (29, x 95)/268 = 10.28 (expected frequency with an
unconfirmed diagnosis of chronic 
obstructive pulmonary disease)
(7) Restrictive Pulmonary Disease Expected Value Calculation
fe = (43 x 173)/268 = 27.76 (expected frequency with a confirmed
diagnosis of restrictive pulmonary 
disease)
fe = (43 x 95)/268 = 15.24 (expected frequency with an
unconfirmed diagnosis of restrictive 
pulmonary disease)
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(8) Density/Nodule/Mass Disease Expected Value Calculation
fe = (104 x 173)/268 = 67.13 (expected frequency with a confirmed
diagnosis of density/nodule/mass 
disorder)
fe = (104 x 95)/268 = 36.87 (expected frequency with an
unconfirmed diagnosis of 
density/nodule/mass disorder)
(9) Miscellaneous Disorder Expected Value Calculation
fe = (92 x 173)/268 = 59.39 (expected frequency with a confirmed
diagnosis of miscellaneous disorder)
fe = (92 x 95)/268 = 32.61 (expected frequency with an













Chronic Obstructive 24 5 29
Pulmonary Disease
(18.72)* (10.28)
Restrictive Pulmonary Disease 32 11 43
(27.76) (15.24)
Density/Nodule/Mass 37 67 104
(67.13) (36.87)
Miscellaneous Disorders 80 12 92
(59.39) (32.61)
TOTAL 173 95 268
‘Expected values are presented in parenthesis
(10) Chi-Square Analysis Calculation
X2 = E  (fo - fe)2 
fe
X2 = (24 - 18.72)2/18.72 + (32 - 27.76)2/27.76 + (37 - 67.13)2/67.13 + 
(80 - 59.39)759.39 + (5 - 10.28)710.28 + (11 - 15.24)715.24 + 
(67 - 36.87)736.87 + (12 - 32.61)732.61 
X2= 1.49 + 0.65 + 13.52 + 7.15 + 2.71 + 1.18 + 24.62 + 13.03 
X2 = 64.35
ARTHUR LAKES LIBRARY 
COLORADO SCHOOL OF MINES 
001DEN.C0 80401
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When comparing the chi-square value of 64.35 to the Distribution of X2 
Probability Table (Munro and others, 1986), using three degrees of freedom it is evident 
that 64.35 is highly significant beyond the .001 level (the tabled value for .001 is 16.266). 
Therefore, the null hypothesis, that a diagnosis that both the radiologist and the 
participant's personal physician agree upon is independent of the lung disorder, must be 
rejected. The conclusion from this test is that agreement between the radiologist and 
personal physician is highly dependent on the lung disorder. Therefore, based on this 
statistical test the chest x-ray is a good screening tool for some lung disorders, but not all.
5.3 Analysis of the Database
When examining the data without any statistical evaluation it appears that the chest 
x-ray is a good screening tool, if a 70 percent or less accuracy is required, for chronic 
obstructive pulmonary disease, restrictive pulmonary disease, and miscellaneous disorders. 
Upon further evaluation of the data collected in this study, with the use of 95 percentile 
confidence intervals it was confirmed that the chest x-ray is a good screening tool for 
specific lung disorders (i.e., chronic obstructive pulmonary disease, restrictive pulmonary 
disease, and miscellaneous disorders) except the density/nodule/mass disorder.
The chi-square test revealed that the chest x-ray, as diagnosed by the ILO 
classification system is highly dependent on the specific lung disorder. In other words, it is 
more likely that the radiologist and personal physician will agree on a diagnosis with some 
lung disorders and not with others.
The interviewer did observe during the study that a large number of participants 
who had been diagnosed by the radiologist with a density/nodule/mass disorder that their
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personal physician concluded that the radiologist was seeing the participant's nipples on 
the chest x-ray. This may have been one of the reasons that the density/nodule/mass 
disorder was confirmed at such a lower rate when compared to the other lung disorders.
As discussed earlier, the ILO classification system was developed as a tool for 
diagnosis of Coal Workers Pneumoconiosis. It is a useful tool for the evaluation of 
effects of exposure to dusty atmospheres (Albin and others, 1992). The ILO 
classification provides two pieces of information, categorization of the size or form of 
opacities from dust exposure and an indication of their profusion or extent in the lung 
fields. It is most useful in relating the radiographic features to dust exposures and 
changes in lung function (Weill and Tumer-Warwick, 1981) not to potential lung cancer. 
When a B-reader identifies a density/nodule/mass disorder there is a possibility that this 
diagnosis is a lung cancer or the observed abnormality may be a benign spot on the lung 
that has no significance.
According to the United States Preventive Services Task Force (1990) in 
Washington, D.C. chest x-rays lack sufficient accuracy to be used as a screening tool for 
potential lung cancers. Accuracy of the chest x-ray is limited by the technology and by 
variation in interpretation among the B-readers. These standard chest x-ray films used 
for the ILO classification system provide examples of abnormalities specific to 
pneumoconioses and include such features as pleural thickening and cardiac 
abnormalities (Parkes, 1982).
The chest x-ray as an overall screening tool for workplace exposures should be 
used only when its limitations are understood by the user and the information is used in 




The second hypothesis of this study was that if the incidence of lung disorders 
(e.g., chronic obstructive pulmonary disease, restrictive pulmonary disease, 
density/nodule/mass disorders, and miscellaneous disorders) is less than the State of 
Colorado incidence of similar disease. Unfortunately, data on the incidence and 
prevalence of occupational lung disease is essentially nonexistent (Markowitz, 1992). 
The following sections describe several databases that are maintained, but did not offer 
much in the way of comparison for incidence and prevalence rates.
6.1 Chronic Obstructive Pulmonary Disease
The Colorado Division of Workers’ Compensation tracks respiratory disease as it 
relates to lost time claims (Rohrback, 1994). Table 13 is a summary of the number of 
cases of obstructive pulmonary disease. A comparison could not be made between these 
data and the Rocky Flats data because the workers' compensation data track acute 
obstructive pulmonary disease cases and the Rocky Flats data consists of chronic 
obstructive pulmonary disease cases.
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Table 13
Colorado Division of Workers’ Compensation 
Lost Time Claims for 
Obstructive Pulmonary Disease
Nature of Injury Number of Cases
Respiratory (Fumes) 167
Upper Respiratory Condition 5
Respiratory System Condition Unspecified 2
Pneumonia, Bronchitis, Asthma 8
6.2 Restrictive Pulmonary Disease
The Colorado Division of Workers' Compensation also tracks respiratory disease 
as it relates to lost time claims (Rohrback, 1994). Table 14 contains a summary of the 
number of cases of restrictive pulmonaiy disease per 10,000 workers in 1992.
The total number of cases of restrictive pulmonary disease during 1992 was nine. 
The total number of confirmed cases of restrictive pulmonary disease between October 
1991 and January 1993 was 32 in the Rocky Flats study.
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Table 14
Colorado Division of Workers’ Compensation 
Lost Time Claims for 
Restrictive Pulmonary Disease






Since 1979, the State of Colorado has been tracking the cancer incidence in 
Colorado through the Colorado Central Cancer Registry (CCCR). The CCCR estimates 
that it registers approximately 90 percent of the cancer diagnosed in Colorado and 100 
percent of the cancers diagnosed in the Denver Metropolitan Area. The most recent 
published report is from 1991 and covers 1979 to 1988 (Karp and others, 1991). Table 
15 is a summary of the cancer incidence rates in the Denver Metropolitan Area.
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Table 15
Average Annual Incidence Rate1 
of Lung Cancer per 100,000 Population 
for Overlapping 3-Year Time Periods
Year










23.0 25.3 25.8 25.9 27.9 28.3 31.0 31.8 38.4
1 Age-Adjusted to 1970 United States Standard Population by Direct Method.




This thesis study was a follow-up to the RFETS's original Beryllium Health 
Surveillance Program. The purpose was to determine a final medical diagnosis for each 
abnormal (Category "B") chest x-ray not related to chronic beryllium disease. This was 
accomplished by first determining the final medical diagnosis from each participant's 
personal physician. This information was then compared to the radiologist's report to 
evaluate the effectiveness of the chest x-ray as a screening tool for pre-existing 
pulmonary function disorders. Next, the final medical diagnosis for each participant was 
complied into a database. This database was evaluated and compared to other available 
databases in an effort to determine the incidence of pulmonary disease at RFETS.
Based on the data in this study the chest x-ray, as diagnosed by a certified B- 
reader using the ILO classification system, is a good screening tool, if a 70 percent or 
less accuracy is required, when compared on a percentage basis for chronic obstructive 
pulmonary disease, restrictive pulmonary disease, and certain miscellaneous disorders. 
However, the ILO classification system was not an effective tool for identifying and 
diagnosing density/nodule/mass disorders that may be indications of lung cancer.
The 95 percentile confidence interval calculation confirmed that the overall 
effectiveness of the chest x-ray is an adequate screening tool for the lung disorders (i.e., 
chronic obstructive pulmonary disease, restrictive pulmonary disease, and miscellaneous
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disorders) except for the density/nodule/mass disorder. In addition, the chi-square test 
determined that agreement between the diagnosis of the radiologist and the participant’s 
personal physician is highly dependent on the specific lung disorder.
The second part of this study was intended to determine if the incidence of lung 
disorders (e.g., chronic obstructive pulmonary disease, restrictive pulmonary disease, 
density/nodule/mass disorders, and miscellaneous disorders) in the RFETS groups was 
greater or smaller than the incidence of lung disorders in Colorado. Unfortunately, no 
databases were found that would provide this type of comparison.
This study indicates that the following research studies should be done in the
future:
•  A database of occupational lung disorders should be developed to 
support future studies. Currently no one database exists that provides 
information on the incidence and prevalence of occupational lung 
disorders nationally or at the state level.
•  The final medical diagnosis that was confirmed for each participant in this 
study should be further evaluated by an occupational physician. An 
occupational physician is trained differently from a personal physician and 
may have a different opinion concerning the diagnosis.
•  The chest x-rays in this study were analyzed by two radiologists. It 
would be interesting to cross check their work and see if one radiologist 
was more or less accurate than the other.
It also would be interesting to examine if one lung disorder was more 
easily identified compared to the other lung disorders. This study 
suggested that the miscellaneous disorders were the easiest to identify, 
but based on the history of the ILO classification it seems that the 
restrictive lung disorders should be the easiest to identify.
This study did not look at any participants in Category “A” that were 
considered to have a normal chest x-ray by the radiologist, but their 
personal physician found a problem during the follow-up.
A prospective study needs to be conducted on employees working at 
RFETS to track exposures now and their effects into the future.
Exposure histories need to be compiled for all job classifications at 
RFETS from the start-up of operations in 1952 to the present.
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Abnormal Chest X-Ray Data
October 1991 through January 1993
S t u d y
R e s u l t s
S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
'M a s s M i s c e l l a n e o u s
C o n f i r m e d I 3 7 M Y Y
F i n a l 2 6 0 M Y
M e d i c a l 3 6 5 M Y Y
D i a g n o s i s 4 6 4 M Y Y
5 6 9 M Y Y
6 6 8 M Y
7 4 4 M Y Y
8 5 8 M Y
9 6 5 M Y Y
1 0 7 6 M Y Y Y
1 1 3 3 M •Y
1 2 7 2 M Y
1 3 6 4 M Y Y
1 4 7 5 M Y
1 5 6 8 M Y Y
1 6 4 7 F Y
1 7 6 4 M Y Y
1 8 5 2 M Y Y
1 9 7 6 M Y Y
2 0 7 6 M Y Y
2 1 7 0 M Y Y Y
2 2 7 5 M Y Y Y
2 3 6 0 M Y Y Y
2 4 7 4 M Y Y
2 5 6 9 M Y Y
2 6 7 1 M Y
2 7 6 7 M Y Y Y
2 8 6 8 M Y Y Y Y
2 9 6 4 M Y
3 0 5 6 M Y Y
3 1 6 7 F Y Y
3 2 6 1 M Y Y
3 3 7 0 M Y Y
3 4 6 9 M Y Y Y
3 5 6 9 M Y Y
3 6 5 6 M Y Y Y
3 7 7 6 M Y Y Y
3 8 5 8 M Y Y
3 9 7 4 M Y Y Y
4 0 7 1 M Y
4 1 6 1 M Y
4 2 4 7 M Y Y
4 3 5 4 M Y




Abnormal Chest X-Ray Data
October 1991 through January 1993
S t u d y
R e s u l t s
S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
C o n f i r m e d 4 5 7 1 M Y Y
F i n a l 4 6 6 1 M Y Y Y
M e d i c a l 4 7 7 3 M Y Y
D i a g n o s i s 4 8 4 8 M Y Y
( c o n t i n u e d ) 4 9 6 7 M Y Y
5 0 5 9 M Y
5 1 6 0 M Y Y
5 2 7 5 M Y Y
5 3 7 4 M Y Y Y
5 4 3 9 M Y Y
5 5 6 2 M Y Y Y
5 6 8 1 M Y Y
5 7 6 8 M Y Y Y Y
5 8 6 1 M Y Y
5 9 7 1 M Y Y
6 0 4 8 M Y Y
6 1 4 6 F Y
6 2 6 8 M Y Y Y
6 3 7 2 M Y Y
6 4 5 1 M Y
6 5 6 7 M Y Y
6 6 6 2 M Y Y
6 7 4 5 M Y Y
6 8 8 0 M Y Y Y
6 9 7 5 M Y Y
7 0 5 3 M Y Y
7 1 7 9 M Y
7 2 4 4 F Y Y
7 3 5 2 F Y Y
7 4 4 6 M Y
7 5 7 1 M Y
7 6 5 8 M Y Y
7 7 6 2 M Y Y
7 8 7 5 M Y Y
7 9 6 5 M Y Y
8 0 7 8 M Y Y
8 1 5 9 M Y Y Y
8 2 8 2 M Y
8 3 7 6 M Y Y Y
8 4 7 3 M Y Y
8 5 5 6 M Y Y
8 6 6 9 M Y Y
8 7 8 3 M Y Y




Abnormal Chest X-Ray Data
October 1991 through January 1993
S t u d y
R e s u l t s
S t u d y
U A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
C o n f i r m e d 89 6 6 M Y Y
F i n a l 9 0 5 2 M Y Y
M e d i c a l 9 1 4 5 M Y
D i a g n o s i s 9 2 6 5 M Y
( c o n t i n u e d ) 9 3 4 4 M Y Y
9 4 7 6 M Y Y
9 5 6 6 M Y Y
9 6 7 8 M Y Y
9 7 7 7 M Y Y Y
9 8 6 1 M Y Y
9 9 7 0 M Y Y
1 0 0 6 2 M Y Y
1 0 1 6 3 M Y
1 0 2 7 4 M Y
1 0 3 7 3 M Y Y
1 0 4 6 7 M Y
1 0 5 5 4 M Y Y
1 0 6 7 5 M Y Y
1 0 7 6 6 M Y
1 0 8 5 9 M Y
1 0 9 6 9 M Y Y Y Y
1 1 0 5 9 M Y Y
1 1 1 4 5 M Y
1 1 2 6 5 M Y Y
1 1 3 7 2 M Y Y
1 1 4 7 1 M Y Y
1 1 5 8 7 M Y Y Y
1 1 6 7 2 M Y Y Y
1 1 7 3 1 M Y
1 1 8 5 3 M Y Y Y
1 1 9 6 9 M Y Y
1 2 0 5 4 M Y
1 2 1 5 0 M Y Y
1 2 2 6 2 M Y Y
1 2 3 6 3 M Y
1 2 4 7 1 M Y Y Y
1 2 5 7 6 M Y Y
1 2 6 7 1 M Y
1 2 7 7 6 M Y Y
A b n o r m a l 1 2 8 7 7 M Y Y
C h e s t  x > R a y s 1 2 9 6 5 M Y
t h a t  w e r e 1 3 0 4 5 M Y Y
D i a g n o s e d  a s 1 3 1 6 4 M Y Y




Abnormal Chest X-Ray Data
October 1991 through January 1993
S t u d y
R e s u l t s
S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
A b n o r m a l 1 3 3 7 0 M Y Y
C h e s t 1 3 4 6 6 M Y Y
x - R a y s  t h a t 1 3 5 4 3 M Y
w e r e  L a t e r 1 3 6 6 2 M Y Y
D i a g n o s e d  a s 1 3 7 5 4 M Y Y
N o r m a l 1 3 8 6 7 M Y Y
( C o n t i n u e d ) 1 3 9 6 7 M Y Y Y
1 4 0 7 9 M Y
1 4 1 5 8 M Y
1 4 2 7 2 M Y Y
1 4 3 5 8 M Y Y
1 4 4 4 5 M Y
1 4 5 3 9 M Y
1 4 6 5 4 M Y Y Y
1 4 7 6 8 M Y Y
1 4 8 5 6 M Y Y
1 4 9 7 7 M Y Y
1 5 0 7 1 M Y Y Y
1 5 1 4 5 M Y
1 5 2 4 3 F Y
1 5 3 7 0 M Y Y
1 5 4 6 0 M Y Y
1 5 5 6 3 M Y Y
1 5 6 4 8 M Y
1 5 7 6 6 M Y Y Y
1 5 8 5 0 M Y Y
1 5 9 4 1 M Y Y
1 6 0 5 1 M Y Y
1 6 1 7 0 M Y Y
1 6 2 4 2 M Y Y
1 6 3 7 0 M Y
1 6 4 5 3 M Y Y
1 6 5 6 6 M Y Y
1 6 6 5 4 M Y Y
1 6 7 6 8 M Y
1 6 8 7 7 M Y
1 6 9 8 6 M Y Y
1 7 0 4 5 M Y Y
1 7 1 8 0 M Y
1 7 2 7 1 M Y Y
1 7 3 5 8 M Y Y
1 7 4 7 0 M Y
1 7 5 5 4 M Y Y




Abnormal Chest X-Ray Data
October 1991 through January 1993
S t u d y
R e s u l t s
S t u d y
M A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
A b n o r m a l 1 7 7 3 9 M Y Y
C h e s t 1 7 8 4 5 M Y
x - R a y s  t h a t 1 7 9 7 5 F Y Y Y
w e r e  L a t e r 1 8 0 6 5 M Y Y
D i a g n o s i e d  a s 1 8 1 6 2 M Y Y
N o r m a l 1 8 2 7 2 M Y Y
( c o n t i n u e d ) 1 8 3 6 6 M Y Y
1 8 4 7 6 M Y Y
1 8 5 4 5 M Y
1 8 6 5 2 M Y
1 8 7 4 3 M Y Y
1 8 8 7 4 M Y Y
1 8 9 6 6 M Y Y
1 9 0 7 0 M Y
1 9 1 5 9 M Y Y
1 9 2 6 5 M Y Y
1 9 3 5 4 M Y
1 9 4 4 5 F Y
1 9 5 7 1 M Y Y
1 9 6 4 2 F Y
1 9 7 5 8 M Y
1 9 8 7 1 M Y
1 9 9 4 8 M Y
2 0 0 6 3 M Y Y
2 0 1 6 1 M Y
2 0 2 3 8 M Y
2 0 3 6 7 M Y Y
2 0 4 7 0 M Y
2 0 5 6 0 M Y
2 0 6 7 1 M Y Y
2 0 7 6 7 M Y
2 0 8 6 1 M Y Y Y
2 0 9 6 1 M Y Y
2 1 0 5 8 M Y Y
2 1 1 4 7 M Y Y
2 1 2 6 8 M Y Y
2 1 3 6 9 M Y Y
2 1 4 5 1 M Y
2 1 5 5 3 M Y
2 1 6 7 5 M Y Y
2 1 7 6 0 M Y
2 1 8 7 0 M Y




Abnormal Chest X-Ray Data
October 1991 through January 1993
S t u d y
R e s u l t s
S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
M o d u le /
M a s s M i s c e l l a n e o u s
2 2 0 6 1 M Y Y Y
P a r t i c i p a n t 2 2 1 4 5 M Y Y
d i d  n o t 2 2 2 7 4 M Y
C o m m u n i c a t e 2 2 3 5 3 M Y Y
w i t h  t h e i r 2 2 4 7 5 M Y
P e r s o n a l 2 2 5 6 5 F Y
P h y s i c i a n 2 2 6 7 1 M Y Y Y
2 2 7 7 1 M Y Y
2 2 8 7 3 M Y Y
2 2 9 7 8 M Y Y
2 3 0 4 2 M Y Y
2 3 1 6 5 M Y Y
2 3 2 6 9 F Y Y
2 3 3 7 4 M Y Y Y
2 3 4 6 0 M Y Y Y
2 3 5 6 7 M Y Y Y
2 3 6 4 0 M Y
2 3 7 3 3 M Y
2 3 8 4 6 M Y
2 3 9 7 4 M Y Y
2 4 0 5 3 M Y Y Y
2 4 1 6 6 M Y Y
2 4 2 6 3 M Y Y
2 4 3 3 9 M Y
2 4 4 5 5 M Y
2 4 5 5 9 M Y Y
2 4 6 7 9 M Y Y
2 4 7 7 6 M Y Y
2 4 8 6 0 M Y Y
2 4 9 4 8 M Y Y
2 5 0 5 3 M Y Y
2 5 1 5 2 F Y Y
2 5 2 3 9 M Y Y
2 5 3 5 9 M Y Y Y
2 5 4 6 1 F Y Y
2 5 5 5 0 M Y
2 5 6 6 8 M Y Y
2 5 7 6 4 M Y Y
2 5 8 7 0 M Y Y
2 5 9 6 3 M Y Y
2 6 0 6 9 M Y Y Y Y
2 6 1 6 2 M Y Y Y Y




Abnormal Chest X-Ray Data
October 1991 through January 1993
S t u d y
R e s u l t s
S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
P a r t i c i p a n t 2 6 3 4 5 M Y Y
d i d  n o t 2 6 4 6 7 M Y Y Y
C o m m u n i c a t e 2 6 3 5 2 M Y
w i t h  t h e i r 2 6 6 6 0 M Y Y
P e r s o n a l 2 6 7 4 9 M Y
P h y s i c i a n 2 6 8 7 6 M Y
( c o n t i n u e d ) 2 6 9 6 3 M Y Y
2 7 0 4 9 M Y Y
2 7 1 7 5 M Y Y
2 7 2 7 4 M Y Y Y
2 7 3 4 7 M Y Y
2 7 4 3 9 M Y Y
2 7 5 6 9 M Y Y Y
2 7 6 7 0 M Y Y Y Y
2 7 7 4 3 M Y Y
2 7 8 4 3 M Y Y
2 7 9 6 2 M Y Y Y
2 8 0 8 0 M Y Y
2 8 1 5 5 M Y
P a r t i c i p a n t 2 8 2 8 0 M Y Y
i s 2 8 3 7 9 M Y Y
D e c e a s e d 2 8 4 8 1 M Y Y Y
2 8 3 8 5 M Y Y
2 8 6 6 6 M Y Y
2 8 7 8 0 M Y Y
2 8 8 6 8 M Y Y
P a r t i c i p a n t 2 8 9 7 3 M Y Y Y Y
P r o v i d e d  n o 2 9 0 4 5 M Y
F o r w a r d i n g 2 9 1 4 9 M Y
A d d r e s s  car 2 9 2 7 0 M Y Y
C h o s e 2 9 3 5 3 M Y Y
t o  W i t h d r a w 2 9 4 7 1 M Y Y Y
2 9 5 5 6 M Y
2 9 6 6 3 F Y Y
2 9 7 6 0 F Y
2 9 8 4 5 M Y Y
2 9 9 6 3 M Y Y Y
3 0 0 5 9 M Y Y
3 0 1 5 8 M Y
3 0 2 5 3 M Y
3 0 3 4 8 M Y Y
3 0 4 3 7 M Y




Abnormal Chest X-Ray Data
October 1991 through January 1993
S t u d y
R e s u l t s
S t u d y
n A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
P a r t i c i p a n t 306 6 2 M Y Y
P r o v i d e d  n o 3 0 7 6 0 M Y Y
F o r w a r d i n g 3 0 9 4 4 F Y Y
A d d r e s s  o r 3 1 0 6 6 M Y Y
C h o s e  t o 3 1 1 4 5 M Y
W i t h d r a w 3 1 2 6 2 M Y Y
( c o n t i n u e d ) 3 1 3 6 9 M Y Y Y
3 1 4 3 5 M Y
3 1 5 7 0 M Y Y Y
3 1 6 8 4 M Y Y Y
3 1 7 4 9 M Y
3 1 8 2 8 M Y Y
3 1 9 6 8 M Y Y Y
3 2 0 7 3 M Y Y Y
3 2 1 7 5 F Y Y Y
3 2 2 7 7 M Y Y Y
3 2 3 5 6 M Y Y
3 2 4 4 5 M Y
3 2 5 6 1 M Y Y
3 2 6 4 9 M Y Y
3 2 7 4 5 M Y
3 2 8 4 5 M Y Y
3 2 9 6 1 M Y Y
3 3 0 6 8 M Y
3 3 1 7 1 F Y Y
3 3 2 6 7 M Y Y
3 3 3 5 6 M Y Y
3 3 4 7 0 M Y Y
3 3 5 4 5 M Y Y
3 3 6 4 5 M Y
3 3 7 4 1 M Y Y
3 3 8 5 0 M Y Y
3 3 9 5 6 M Y
3 4 0 7 1 F Y
P a r t i c i p a n t s 3 4 1 7 3 M Y
d i d 3 4 2 3 8 M Y Y
n o t  r e s p o n d 3 4 3 5 5 F Y
t o  t h e  l e t t e r 3 4 4 6 7 M Y
3 4 5 6 1 M Y Y
3 4 6 7 3 M Y Y
3 4 7 7 1 M Y Y Y
3 4 8 7 0 M Y Y




Abnormal Chest X-Ray Data
October 1991 through January 1993
S t u d y
R e s u l t s
S t u d y
it A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
P a r t i c i p a n t 3 3 0 5 1 M Y Y Y
d i d  n o t 3 5 1 7 7 M Y Y *
r e s p o n d  t o 3 5 2 5 7 M Y Y
t h e  l e t t e r 3 5 3 4 8 M Y Y
( c o n t i n u e d ) 3 5 4 4 3 M Y Y Y
3 5 5 6 2 M Y *
3 5 6 6 9 M Y Y
3 5 7 5 4 M Y Y
3 5 8 4 1 M Y
3 5 9 4 0 M Y
3 6 0 6 4 F Y
3 6 1 5 8 M Y
3 6 2 5 0 M Y
3 6 1 5 8 M Y
3 6 2 5 0 M Y
3 6 3 4 8 M Y
3 6 4 6 4 M Y Y
3 6 5 6 0 M Y Y
3 6 6 5 2 M Y Y Y
_____ 3 6 2 _____ M Y Y  _
Y = Condition exists or was suspected to exist for that participant
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Table A-2
Total Participants with a
Final Medical Diagnosis
S t u d y
R e s u l t s S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
C o n f i r m e d 1 3 7 M Y Y
F i n a l 2 6 0 M Y
M e d i c a l 3 6 5 M Y Y
D i a g n o s i s 4 6 4 M Y Y
5 6 9 M Y Y
6 6 8 M Y
7 4 4 M Y Y
8 5 8 M Y
9 6 5 M Y Y
1 0 7 6 M Y Y Y
1 1 3 3 M Y
1 2 7 2 M Y
1 3 6 4 M Y Y
1 4 7 5 M Y
1 5 6 8 M Y Y
1 6 4 7 F Y
1 7 6 4 M Y Y
1 8 5 2 M Y Y
1 9 7 6 M Y Y
2 0 7 6 M Y Y
2 1 7 0 M Y Y Y
2 2 7 5 M Y Y Y
2 3 6 0 M Y Y Y
2 4 7 4 M Y Y
2 5 6 9 M Y Y
2 6 7 1 M Y
2 7 6 7 M Y Y Y
2 8 6 8 M Y Y Y Y
2 9 6 4 M Y
3 0 5 6 M Y Y
3 1 6 7 F Y Y
3 2 6 1 M Y Y
3 3 7 0 M Y Y
3 4 6 9 M Y Y Y
3 5 6 9 M Y Y
3 6 5 6 M Y Y Y
3 7 7 6 M Y Y Y
3 8 5 8 M Y Y
3 9 7 4 M Y Y Y
4 0 7 1 M Y
4 1 6 1 M Y
4 2 4 7 M Y Y
4 3 5 4 M Y




Total Participants with a
Final Medical Diagnosis
S t u d y
R e s u l t s S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
C o n f i r m e d 4 5 7 1 M Y Y
F i n a l 4 6 6 1 M Y Y Y
M e d i c a l 4 7 7 3 M Y Y
D i a g n o s i s 4 8 4 8 M Y Y
( c o n t i n u e d ) 4 9 6 7 M Y Y
5 0 5 9 M Y
5 1 6 0 M Y Y
5 2 7 5 M Y Y
5 3 7 4 M Y Y Y
5 4 3 9 M Y Y
5 5 6 2 M Y Y Y
5 6 8 1 M Y Y
5 7 6 8 M Y Y Y Y
5 8 6 1 M Y Y
5 9 7 1 M Y Y
6 0 4 8 M Y Y
6 1 4 6 F Y
6 2 6 8 M Y Y Y
6 3 7 2 M Y Y
6 4 5 1 M Y
6 5 6 7 M Y Y
6 6 6 2 M Y Y
6 7 4 5 M - Y Y
6 8 8 0 M Y Y Y
6 9 7 5 M Y Y
7 0 5 3 M Y Y
7 1 7 9 M Y
7 2 4 4 F Y Y
7 3 5 2 F Y Y
7 4 4 6 M Y
7 5 7 1 M Y
7 6 5 8 M Y Y
7 7 6 2 M Y Y
7 8 7 5 M Y Y
7 9 6 5 M Y Y
8 0 7 8 M Y Y
8 1 5 9 M Y Y Y
8 2 8 2 M Y
8 3 7 6 M Y Y Y
8 4 7 3 M Y Y
8 5 5 6 M Y Y
8 6 6 9 M Y Y
8 7 8 3 M Y Y




Total Participants with a
Final Medical Diagnosis
S t u d y
R e s u l t s S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
C o n f i r m e d 8 9 6 6 M Y Y
F i n a l 9 0 5 2 M Y Y
M e d i c a l 9 1 4 5 M Y
D i a g n o s i s 9 2 6 5 M Y
( c o n t i n u e d ) 9 3 4 4 M Y Y
9 4 7 6 M Y Y
9 5 6 6 M Y Y
9 6 7 8 M Y Y
9 7 7 7 M Y Y Y
9 8 6 1 M Y Y
9 9 7 0 M Y Y
1 0 0 6 2 M Y Y
1 0 1 6 3 M Y
1 0 2 7 4 M Y
1 0 3 7 3 M Y Y
1 0 4 6 7 M Y
1 0 5 5 4 M Y Y
1 0 6 7 5 M Y Y
1 0 7 6 6 M Y
1 0 8 5 9 M Y
1 0 9 6 9 M Y Y Y Y
1 1 0 5 9 M Y Y
1 1 1 4 5 M Y
1 1 2 6 5 M Y Y
1 1 3 7 2 M Y Y
1 1 4 7 1 M Y Y
1 1 5 8 7 M Y Y Y
1 1 6 7 2 M Y Y Y
1 1 7 3 1 M Y
1 1 8 5 3 M Y Y Y
1 1 9 6 9 M Y Y
1 2 0 5 4 M Y
1 2 1 5 0 M Y Y
1 2 2 6 2 M Y Y
1 2 3 6 3 M Y
1 2 4 7 1 M Y Y Y
1 2 5 7 6 M Y Y
1 2 6 7 1 M Y
1 2 7 7 6 M Y Y
A b n o r m a l 1 2 8 7 7 M Y Y
C h e s t  x - R a y s 1 2 9 6 5 M Y
t h a t  w e r e 1 3 0 4 5 M Y Y
L a t e r 1 3 1 6 4 M Y Y




Total Participants with a 
Final Medical Diagnosis
S t u d y
R e s u l t s S t u d y
U A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
A b n o r m a l 1 3 3 7 0 M Y Y
C h e s t 1 3 4 6 6 M Y Y
x - R a y s 1 3 5 4 3 M Y
t h a t  w e r e 1 3 6 6 2 M Y Y
t 1 3 7 5 4 M Y Y
D i a g n o s e d 1 3 8 6 7 M Y Y
a s  N o r m a l 1 3 9 6 7 M Y Y Y
( c o n t i n u e d ) 1 4 0 7 9 M Y
1 4 1 5 8 M Y
1 4 2 7 2 M Y Y
1 4 3 5 8 M Y Y
1 4 4 4 5 M Y
1 4 5 3 9 M Y
1 4 6 5 4 M Y Y Y
1 4 7 6 8 M Y Y
1 4 8 5 6 M Y Y
1 4 9 7 7 M Y Y
1 5 0 7 1 M Y Y Y
1 5 1 4 5 M Y
1 5 2 4 3 F Y
1 5 3 7 0 M Y Y
1 5 4 6 0 M Y Y
1 5 5 6 3 M Y Y
1 5 6 4 8 M Y
1 5 7 6 6 M Y Y Y
1 5 8 5 0 M Y Y
1 5 9 4 1 M Y Y
1 6 0 5 1 M Y Y
1 6 1 7 0 M Y Y
1 6 2 4 2 M Y Y
1 6 3 7 0 M Y
1 6 4 5 3 M Y Y
1 6 5 6 6 M Y Y
1 6 6 5 4 M Y Y
1 6 7 6 8 M Y
1 6 8 7 7 M Y
1 6 9 8 6 M Y Y
1 7 0 4 5 M Y Y
1 7 1 8 0 M Y
1 7 2 7 1 M Y Y
1 7 3 5 8 M Y Y
1 7 4 7 0 M Y
1 7 5 5 4 M Y Y




Total Participants with a
Final Medical Diagnosis
S t u d y
R e s u l t s S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
A b n o r m a l 1 7 7 3 9 M Y Y
C h e s t 1 7 8 4 5 M Y
x > R a y s 1 7 9 7 5 F Y Y Y
t h a t  w e r e 1 8 0 6 5 M Y Y
L a t e r 1 8 1 6 2 M Y Y
D i a g n o s e d 1 8 2 7 2 M Y Y
a s  N o r m a l 1 8 3 6 6 M Y Y
( c o n t i n u e d ) 1 8 4 7 6 M Y Y
1 8 3 4 5 M Y
1 8 6 5 2 M Y
1 8 7 4 3 M Y Y
1 8 8 7 4 M Y Y
1 8 9 6 6 M Y Y
1 9 0 7 0 M Y
1 9 1 5 9 M Y Y
1 9 2 6 5 M Y Y
1 9 3 5 4 M Y
1 9 4 4 5 F Y
1 9 5 7 1 M Y Y
1 9 6 4 2 F Y
1 9 7 5 8 M Y
1 9 8 7 1 M Y
1 9 9 4 8 M Y
2 0 0 6 3 M Y Y
2 0 1 6 1 M Y
2 0 2 3 8 M Y
2 0 3 6 7 M Y Y
2 0 4 7 0 M Y
2 0 3 6 0 M Y
2 0 6 7 1 M Y Y
2 0 7 6 7 M Y
2 0 8 6 1 M Y Y Y
2 0 9 6 1 M Y Y
2 1 0 5 8 M Y Y
2 1 1 4 7 M Y Y
2 1 2 6 8 M Y Y
2 1 3 6 9 M Y Y
2 1 4 5 1 M Y
2 1 5 5 3 M Y
2 1 6 7 5 M Y Y




Total Participants with a
Final Medical Diagnosis
S t u d y
R e s u l t s S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
2 1 8 7 0 M Y
2 1 9 2 7 M Y
2 2 0 6 1 M Y Y Y
Y = Condition exists or was suspected to exist for that participant
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Table A-3 
Total Participants with a Final Medical Diagnosis 
Distribution by Age
S t u d y
R e s u l t s S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
C o n f i r m e d 1 3 7 M Y Y
F i n a l 2 6 0 M Y
M e d i c a l 3 6 5 M Y Y
D i a g n o s i s 4 6 4 M Y Y
5 6 9 M Y Y
6 6 8 M Y
7 4 4 M Y Y
8 5 8 M Y
9 6 5 M Y Y
1 0 7 6 M Y Y Y
11 3 3 M Y
1 2 7 2 M Y
1 3 6 4 M Y Y
1 4 7 5 M Y
1 3 6 8 M Y Y
1 6 4 7 F Y
1 7 6 4 M Y Y
1 8 5 2 M Y Y
1 9 7 6 M Y Y
2 0 7 6 M Y Y
2 1 7 0 M Y Y Y
2 2 7 5 M Y Y Y
2 3 6 0 M Y Y Y
2 4 7 4 M Y Y
2 5 6 9 M Y Y
2 6 7 1 M Y
2 7 6 7 M Y Y Y
2 8 6 8 M Y Y Y Y
2 9 6 4 M Y
3 0 5 6 M Y Y
3 1 6 7 F Y Y
3 2 6 1 M Y Y
3 3 7 0 M Y Y
3 4 6 9 M Y Y Y
3 5 6 9 M Y Y
3 6 5 6 M Y Y Y
3 7 7 6 M Y Y Y
3 8 5 8 M Y Y
3 9 7 4 M Y Y Y
4 0 7 1 M Y
4 1 6 1 M Y
4 2 4 7 M Y Y
4 3 5 4 M Y




Total Participants with a Final Medical Diagnosis
Distribution by Age
S t u d y
R e s u l t s S t u d y
n A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
C o n f i r m e d 4 5 7 1 M Y Y
F i n a l 4 6 6 1 M Y Y Y
M e d i c a l 4 7 7 3 M Y Y
D i a g n o s i s 4 8 4 8 M Y Y
( c o n t i n u e d ) 4 9 6 7 M Y Y
5 0 5 9 M Y
5 1 6 0 M Y Y
5 2 7 5 M Y Y
5 3 7 4 M Y Y Y
5 4 3 9 M Y Y
5 5 6 2 M Y Y Y
5 6 8 1 M Y Y
5 7 6 8 M Y Y Y Y
5 8 6 1 M Y Y
5 9 7 1 M Y Y
6 0 4 8 M Y Y
6 1 4 6 F Y
6 2 6 8 M Y Y Y
6 3 7 2 M Y Y
6 4 5 1 M Y
6 5 6 7 M Y Y
6 6 6 2 M Y Y
6 7 4 5 M Y Y
6 8 8 0 M Y Y Y
6 9 7 5 M Y Y
7 0 5 3 M Y Y
7 1 7 9 M Y
7 2 4 4 F Y Y
7 3 5 2 F Y Y
7 4 4 6 M Y
7 5 7 1 M Y
7 6 5 8 M Y Y
7 7 6 2 M Y Y
7 8 7 5 M Y Y
7 9 6 5 M Y Y
8 0 7 8 M Y Y
8 1 5 9 M Y Y Y
8 2 8 2 M Y
8 3 7 6 M Y Y Y
8 4 7 3 M Y Y
8 5 5 6 M Y Y
8 6 6 9 M Y Y
8 7 8 3 M Y Y




Total Participants with a Final Medical Diagnosis
Distribution by Age
S t u d y
R e s u l t s S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
C o n f i r m e d 8 9 6 6 M Y Y
F i n a l 9 0 5 2 M Y Y
M e d i c a l 9 1 4 5 M Y
D i a g n o s i s 9 2 6 5 M Y
( c o n t i n u e d ) 9 3 4 4 M Y Y
9 4 7 6 M Y Y
9 5 6 6 M Y Y
9 6 7 8 M Y Y
9 7 7 7 M Y Y Y
9 8 6 1 M Y Y
9 9 7 0 M Y Y
1 0 0 6 2 M Y Y
1 0 1 6 3 M Y
1 0 2 7 4 M Y
1 0 3 7 3 M Y Y
1 0 4 6 7 M Y
1 0 5 5 4 M Y Y
1 0 6 7 5 M Y Y
1 0 7 6 6 M Y
1 0 8 5 9 M Y
1 0 9 6 9 M Y Y Y Y
1 1 0 5 9 M Y Y
1 1 1 4 5 M Y
1 1 2 - 6 5 M Y Y
1 1 3 7 2 M Y Y
1 1 4 7 1 M Y Y
1 1 5 8 7 M Y Y Y
1 1 6 7 2 M Y Y Y
1 1 7 3 1 M Y
1 1 8 5 3 M Y Y Y
1 1 9 6 9 M Y Y
1 2 0 5 4 M Y
1 2 1 5 0 M Y Y
1 2 2 6 2 M Y Y
1 2 3 6 3 M Y
1 2 4 7 1 M Y Y Y
1 2 5 7 6 M Y Y
1 2 6 7 1 M Y
1 2 7 7 6 M Y Y
A b n o r m a l 1 2 8 7 7 M Y Y
C h e s t  x - R a y s 1 2 9 6 5 M Y
t h a t  w e r e 1 3 0 4 5 M Y Y
L a t e r 1 3 1 6 4 M Y Y




Total Participants with a Final Medical Diagnosis 
Distribution by Age
S t u d y
R e s u l t s S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
A b n o r m a l 1 3 3 7 0 M Y Y
C h e s t 1 3 4 6 6 M ,  Y Y
x - R a y s 1 3 5 4 3 M Y
t h a t  w e r e 1 3 6 6 2 M Y Y
L a t e r 1 3 7 5 4 M Y Y
D i a g n o s e d 1 3 8 6 7 M Y Y
a s  N o r m a l 1 3 9 6 7 M Y Y Y
( c o n t i n u e d ) 1 4 0 7 9 M Y
1 4 1 5 8 M Y
1 4 2 7 2 M Y Y
1 4 3 5 8 M Y Y
1 4 4 4 5 M Y
1 4 5 3 9 M Y
1 4 6 5 4 M Y Y Y
1 4 7 6 8 M Y Y
1 4 8 5 6 M Y Y
1 4 9 7 7 M Y ■ Y
1 5 0 7 1 M Y Y Y
1 5 1 4 5 M Y
1 5 2 4 3 F Y
1 5 3 7 0 M Y Y
1 5 4 6 0 M Y Y
1 5 5 6 3 M Y Y
1 5 6 4 8 M Y
1 5 7 6 6 M Y Y Y
1 5 8 5 0 M Y Y
1 5 9 4 1 M Y Y
1 6 0 5 1 M Y Y
1 6 1 7 0 M Y Y
1 6 2 4 2 M Y Y
1 6 3 7 0 M Y
1 6 4 5 3 M Y Y
1 6 5 6 6 M Y Y
1 6 6 5 4 M Y Y
1 6 7 6 8 M Y
1 6 8 7 7 M Y
1 6 9 8 6 M Y Y
1 7 0 4 5 M Y Y
1 7 1 8 0 M Y
1 7 2 7 1 M Y Y
1 7 3 5 8 M Y Y
1 7 4 7 0 M Y
1 7 5 5 4 M Y Y




Total Participants with a Final Medical Diagnosis
Distribution by Age
S t u d y
R e s u l t s S t u d yn A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
A b n o r m a l 1 7 7 3 9 M Y Y
C h e s t 1 7 8 4 5 M Y
x - R a y s 1 7 9 7 5 F Y Y Y
t h a t  w e r e 1 8 0 6 5 M Y Y
L a t e r 1 8 1 6 2 M Y Y
D i a g n o s e d 1 8 2 7 2 M Y Y
a s  N o r m a l 1 8 3 6 6 M Y Y
( c o n t i n u e d ) 1 8 4 7 6 M Y Y
1 8 3 4 5 M Y
1 8 6 5 2 M Y
1 8 7 4 3 M Y Y
1 8 8 7 4 M Y Y
1 8 9 6 6 M Y Y
1 9 0 7 0 M Y
1 9 1 5 9 M Y Y
1 9 2 6 5 M Y Y
1 9 3 5 4 M Y
1 9 4 4 5 F Y
1 9 5 7 1 M Y Y
1 9 6 4 2 F Y
1 9 7 5 8 M Y
1 9 8 7 1 M Y
1 9 9 4 8 M Y
2 0 0 6 3 M Y Y
2 0 1 6 1 M Y
2 0 2 3 8 M Y
2 0 3 6 7 M Y Y
2 0 4 7 0 M Y
2 0 3 6 0 M Y
2 0 6 7 1 M Y Y
2 0 7 6 7 M Y
2 0 8 6 1 M Y Y Y
2 0 9 6 1 M Y Y
2 1 0 5 8 M Y Y
2 1 1 4 7 M Y Y
2 1 2 6 8 M Y Y
2 1 3 6 9 M Y Y
2 1 4 5 1 M Y
2 1 5 5 3 M Y
2 1 6 7 5 M Y Y
2 1 7 6 0 M Y
2 1 8 7 0 M Y
2 1 9 2 7 M Y
2 2 0 6 1 M Y Y Y
Y = Condition exists or was suspected to exist for that participant
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Table A-4 




D i s t r i b u t i o n
S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
3 0 - 3 9 1 3 7 M Y Y
1 1 3 3 M Y
5 4 3 9 M Y Y
1 1 7 3 1 M Y
4 0 - 4 9 7 4 4 M Y Y
1 6 4 7 F Y
4 2 4 7 M Y Y
4 8 4 8 M Y Y
6 0 4 8 M Y Y
6 1 4 6 F Y
6 7 4 5 M Y Y
7 2 4 4 F Y Y
7 4 4 6 M Y
9 1 4 5 M Y
9 3 4 4 M Y Y
1 1 1 4 5 M Y
5 0 - 5 9 8 5 8 M Y
1 8 5 2 M Y Y
3 0 5 6 M Y Y
3 6 5 6 M Y Y Y
3 8 5 8 M Y Y
4 3 5 4 M Y
5 0 5 9 M Y
6 4 5 1 M Y
7 0 5 3 M Y Y
7 3 5 2 F Y Y
7 6 5 8 M Y Y
8 1 5 9 M Y Y Y
8 5 5 6 M Y Y
9 0 5 2 M Y Y
1 0 5 5 4 M Y Y
1 0 8 5 9 M Y
1 1 0 5 9 M Y Y
1 1 8 5 3 M Y Y Y
1 2 0 5 4 M Y
1 2 1 5 0 M Y Y
6 0 - 6 9 2 6 0 M Y
3 6 5 M Y Y
4 6 4 M Y Y








D i s t r i b u t i o n
S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
6 0 - 6 9 6 6 8 M Y
( c o n t i n u e d ) 9 6 5 M Y Y
1 3 6 4 M Y Y
1 5 6 8 M Y Y
1 7 6 4 M Y Y
2 3 6 0 M Y Y Y
2 5 6 9 M Y Y
2 7 6 7 M Y Y Y
2 8 6 8 M Y Y Y Y
2 9 6 4 M Y
3 1 6 7 F Y Y
3 2 6 1 M Y Y
3 4 6 9 M Y Y Y
3 5 6 9 M Y Y
4 1 6 1 M Y
4 6 6 1 M Y Y Y
4 9 6 7 M Y Y
5 1 6 0 M Y Y
5 5 6 2 M Y Y Y
5 7 6 8 M Y Y Y Y
5 8 6 1 M Y Y
6 2 6 8 M Y Y Y
6 5 6 7 M Y Y
6 6 6 2 M Y Y
7 7 6 2 M Y Y
7 9 6 5 M Y Y
8 6 6 9 M Y Y
8 8 6 6 M Y Y
8 9 6 6 M Y Y
9 2 6 5 M Y
9 5 6 6 M Y Y
9 8 6 1 M Y Y
1 0 0 6 2 M Y Y
1 0 1 6 3 M Y
1 0 4 6 7 M Y
1 0 7 6 6 M Y
1 0 9 6 9 M Y Y Y Y
1 1 2 6 5 M Y Y
1 1 9 6 9 M Y Y
1 2 2 6 2 M Y Y
1 2 3 6 3 M Y








D i s t r i b u t i o n
S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
7 0 - 7 9 1 2 7 2 M Y
( c o n t i n u e d ) 1 4 7 5 M Y
1 9 7 6 M Y Y
2 0 7 6 M Y Y
2 1 7 0 M Y Y Y
2 2 7 5 M Y Y Y
2 4 7 4 M Y Y
2 6 7 1 M Y
3 3 7 0 M Y Y
3 7 7 6 M Y Y Y
3 9 7 4 M Y Y Y
4 0 7 1 M Y
4 4 7 4 M Y
4 5 7 1 M Y Y
4 7 7 3 M Y Y
5 2 7 5 M Y Y
5 3 7 4 M Y Y Y
5 9 7 1 M Y Y
6 3 7 2 M Y Y
6 9 7 5 M Y Y
7 1 7 9 M Y
7 5 7 1 M Y
7 8 7 5 M Y Y
8 0 7 8 M Y Y
8 3 7 6 M Y Y Y
8 4 7 3 M Y Y
9 4 7 6 M Y Y
9 6 7 8 M Y Y
9 7 7 7 M Y Y Y
9 9 7 0 M Y Y
1 0 2 7 4 M Y
1 0 3 7 3 M Y Y
1 0 6 7 5 M Y Y
1 1 3 7 2 M Y Y
1 1 4 7 1 M Y Y
1 1 6 7 2 M Y Y Y
1 2 4 7 1 M Y Y Y
1 2 5 7 6 M Y Y
1 2 6 7 1 M Y








D i s t r i b u t i o n
S t u d y
# A g e S e x S m o k e r
C h r o n i c
O b s t r u c t i v e
P u l m o n a r y
D i s e a s e
R e s t r i c t i v e
P u l m o n a r y
D i s e a s e
D e n s i t y /
N o d u l e /
M a s s M i s c e l l a n e o u s
8 0 - 8 9 5 6 8 1 M Y Y
6 8 8 0 M Y Y Y
8 2 8 2 M Y
8 7 8 3 M Y Y
1 1 5 8 7 M Y Y Y
Y = Condition exists for that participant
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Table A-5 
Total Participants with a Final Confired Medical Diagnosis 










30-39 1 37 M Y Electrician Y
50-59 81 59 M Chemical
Operator
Y
60-69 3 65 M Y Mechanic Y
9 65 M Y Instrument
Repair
Y
23 60 M Y Machinist Y
31 67 F Secretary Y
34 69 M Y Pipefitter Y
46 61 M Y Printer Y
51 60 M Y Chemical
Operator
Y
57 68 M Y Mechanic Y
86 69 M Draftsman Y
109 69 M Y Machinist Y
112 65 M Chemical
Operator
Y
7 0 -7 9 19 76 M Y Machinist Y
21 70 M Y Clerk Y
22 75 M Maintenance Y
33 70 M Maintenance Y
37 76 M Y Tool Grinder Y
45 71 M Y Warehouse Clerk Y
52 75 M Y Electrician Y
69 75 M Y Chemical
Operator
Y
102 74 M Process Operator Y
124 71 M Y Process Operator Y
125 76 M Y Janitor Y
Y = Condition exists for that participant
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Table A-6 
Total Participants with a Final Confirmed Medical Diagnosis of 
Restrictive Pulmonary Disease 
Distribution by Age
Age




40 -49 67 45 M Security Y
93 44 M Y Machinist Y
111 45 M Chemical Operator Y
50-59 18 52 M Pipefitter Y
50 59 M Electrician Y
64 51 M Chemical Operator Y
81 59 M Chemical Operator Y
110 59 M Y Laboratory
Technician
Y
6 0-69 5 69 M Y Electrician Y
13 64 M Machinist Y
15 68 M Y Chemical Operator Y
27 67 M Y Radiation Protection 
Technician
Y
28 68 M Y Engineer Y
55 62 M Y Pipefitter Y
58 61 M Pipefitter Y
86 69 M Draftsman Y
101 63 M Machinist Y
122 62 M Y Janitor Y
7 0-79 10 76 M Y Machinist Y
22 75 M Maintenance Y
39 74 M Y Chemical Operator Y
40 71 M Pipefitter Y
47 73 M Y Pipefitter Y
53 74 M Y Pipefitter Y
59 71 M Y Machinist Y
63 72 M Y Tool Grinder Y
80 78 M Y Chemical Operator Y
83 76 M Y Machinist Y
97 77 M Y Maintenance Y
103 73 M Y Chemical Operator Y
(continued)
ARTHUR LAKES LIBRARY 
COLORADO SCHOOL OF ftSIMES 
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Table A-6
Total Participants with a Final Confirmed Medical Diagnosis of 
Restrictive Pulmonary Disease 
Distribution by Age
Age




80 -89 68 80 M Y Welder Y
115 87 M Y Laundry Worker Y
Y = Condition exists for that participant
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Table A-7 




Distribution # Age Sex Smoker Occupation
Density/
Nodule/Mass
30-39 11 33 M Engineer Y
54 39 M Y Laundry Worker Y
4 0 -4 9 67 45 M Security Y
74 46 M Security Y
91 45 M Process Operator Y
5 0-59 30 56 M Y Process Operator Y
36 56 M Y Laborer Y
76 58 M Y Electrician Y
118 53 M Y Radiation Protection 
Technician
Y
120 54 M Fabricator Y
121 50 M Y Security Y
6 0-69 13 64 M Machinist Y
23 60 M Y Machinist Y
27 67 M Y Radiation Protection 
Technician
Y
28 68 M Y Engineer Y
31 67 F Secretary Y
32 61 M Y Laborer Y
55 62 M Y Pipefitter Y
57 68 M Y Mechanic Y
58 61 M Pipefitter Y
62 68 M Y Inspector Y
77 62 M Engineer Y
95 66 M Process Operator Y
98 61 M Engineer Y
107 66 M Process Operator Y
109 69 M Y Machinist Y
112 65 M Chemical Operator Y
70-79 10 76 M Y Machinist Y
12 72 M Janitor Y
33 70 M Maintenance Y













75 71 M Machinist Y
83 76 M Y Machinist Y
97 77 M Y Maintenance Y
113 72 M Y Machinist Y
116 72 M Y Engineer Y
127 76 M Chemical Operator Y
Y = Condition exists for that participant
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Table A-8 
Total Participants with a Final Confirmed Medical Diagnosis 
of Miscellaneous Disorders 
Distribution by Age
Age
Distribution # Age Sex Smoker Occupation
Miscellaneous
Disorders
30-39 117 31 M Laborer Y
4 0-49 7 44 M Y Process Operator Y
16 47 F Chemical Operator Y
42 47 M Y Radiation Protection 
Technician
Y
48 48 M Y Pipefitter Y
60 48 M Y Laborer Y
61 46 F Secretary Y
72 44 F Y Cafeteria Worker Y
50-59 8 58 M Welder Y
18 52 M Pipefitter Y
36 56 M Y Laborer Y
38 58 M Y Inspector Y
43 54 M Draftsman Y
70 53 M Y Process Operator Y
73 52 F Y Pipefitter Y
81 59 M Chemical Operator Y
85 56 M Y Chemical Operator Y
90 52 M Y Security Y
105 54 M Y Chemical Operator Y
108 59 M Engineer Y
118 53 M Y Radiation Protection 
Technician
Y
60-69 2 60 M Shop Technician Y
4 64 M Y Janitor ' Y
6 68 M Machinist Y
17 64 M Y Welder Y
25 69 M Y Fabricator Y
28 68 M Y Engineer Y
29 64 M Radiation Protection 
Technician
Y
34 69 M Y Pipefitter Y




Total Participants with a Final Confirmed Medical Diagnosis 











































Total Participants with a Final Confirmed Medical Diagnosis 
of Miscellaneous Disorders 
Distribution by Age
Age





106 75 M Y Radiation Protection 
Technician
Y
114 71 M Y Carpenter Y
116 72 M Y Engineer Y
124 71 M Y Process Operator Y
126 71 M Engineer Y
127 76 M Chemical Operator Y
80-89 56 81 M Y Inspector Y
68 80 M Y Welder Y
82 82 M Machinist Y
87 83 M Y Clerk Y
115 87 M Y Laundry Worker Y
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ROCKY FLATS
EG&G ROCKY FLATS, INC.
ROCKY FLATS PLANT, P.O. BOX 464, GOLDEN, COLORADO 80402-0464 ♦ (303) 966-7000
January  14 ,1994 94-RF-0032S
D ear
The Department of Energy, In cooperation with EG&G Rocky Rats, Inc., is initiating a Chest X-ray 
Fotiow-up Program. It is directed at current, retired and former Rocky Fiats Plant employees who 
participated in the Beryllium Health Surveillance Program. This program w as suggested by and has 
the  full support of the United Steelworkers, Local 8031. Enclosed is a  letter from the United 
Steelworkers, Local 8031, encouraging you to participate in this program.
We are  contacting Beryllium Health Surveillance Program participants whose chest x-ray taken as 
part of the Beryllium Health Surveillance Program indicated some atypical findings. I sent you a copy 
of the Rocky Mountain Radiologists chest x-ray report, and strongly suggested that you give this 
report to your private physician.
To participate In this program you will be asked to provide information concerning the chest x-ray you 
had taken a s  part of the Beryllium Health Surveillance Program. You may be able to provide all of the 
Information necessary. However, we may need to contact your private physician regarding this chest 
x-ray.
W e encourage you to participate in this voluntary program, which will be free of charge. If you wish to 
participate in this health program, please sign your name in the appropriate space on the enclosed 
form. Please fill in your name, address, and telephone number on the form, and return by mail in the 
enclosed pre-paid, pre-addressed envelope. You will be contacted and provided additional 
information describing the details of the program.
Your cooperation made the Beryllium Health Surveillance Program successful. Your continued 
participation is essential to the successful completion of this health surveillance program. If you have 
any questions, please call the Rocky Fiats Occupational Health Department collect at 303-965-8373, 
9:00 a.m.-3:00 p.m., Monday through Friday, and ask for the 'Chest X-ray Follow-up Program."
Sincerely,








BERYLLIUM HEALTH SURVEILLANCE PROGRAM  
CHEST X-RAY FOLLOW-UP
As part of the Rocky Flats Plant Beryllium Health Surveillance Program (BHSP) you received a chest x-ray. 
You received a  letter from F. J . Furman, M.D., Director, Rocky Flats Plant, Occupational Health Department 
and a  copy of the Rocky Mountain Radiologists (RMR) radiology report regarding your BHSP chest x-ray. 
This letter stated that the report from RMR showed some atypical findings that were possibly significant, 
but not associated with Chronic Beryllium Disease. On the basis of this report. Dr. Furman strongly 
suggested that you follow up with your primary care physician.
To participate in this program we would like permission to ask you some questions regarding your primary 
care physician's review of the report received from Dr. Furman regarding your chest x-ray taken as part of 
the BHSP. We would also like permission to contact your primary care physician regarding his/her review 
of this report and/or the chest x-ray on which it was based. There Is little or no risk to you from your 
participation in this program. Participation in this program is on a voluntary basis.
If we contact your primary care physician and request information, it will be limited to the chest x-ray dated 
and the report from RMR dated -- taken a s  part of the BHSP. No other
information will be requested from your primary care physician.
The results of this review will be reported to the Rocky Flats Plant Occupational Health and Health Effects 
Departments. If required by law they will also be reported to the Department of Energy (DOE) and the 
Occupational Safety and Health Administration. The records may be provided to other organizations 
within EG&G Rocky Flats, Inc., if a  legitimate need to know exists^such a s  the Legal Department for the 
defense of an action or claim brought against EG&G Rocky Flats, Inc., for which the information is relevant.
Your nam e or other unique identifiers (RFP employee number, social security number, etc.) will not be 
used In any reports generated from this study. No future employer (except for any successor Manager 
and Operator of Rocky Flats), agency, group, organization or person will have access to the information 
provided by you, unless you authorize the release of Information in writing.
I have read the statement above and voluntarily consent to participate In this study. I authorize my primary 
care physician that I name below, to release information or medical opinion concerning the BHSP chest x- 
ray dated .. and RMR report dated I understand that I can withdraw at any
time from participation without prejudice against me.
Physician’s  Name -
Physician’s  Telephone Number __________________________________
Date




T elephone Number Address








R e c o r d in g  S e c r e ta r y
s\'5\0J!££*rli Gary Swenson 
Financial Secretary
Ray Malito fere!!'!,,,*• wr*.T *ViTreasurer
0tsslujcrk?rs of Amsrira
AFL-CIO-CLC
Local Union 8031 4510 Indiana Street Golden, Colorado 80403
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The United Steelworkers, Local 8031, encourages you to participate in this follow-up 
to the Beryltium Health Surveillance Program. The United Steelworkers 
recommended to the Department of Energy that a program such as this be undertaken. 
The program is directed at individuals who had a chest x-ray taken as part of the 
Beryllium Health Surveillance Program and received a report from Rocky Mountain 
Radiologists which indicated atypical findings, which were possibly significant.
The Steelworkers believe that continued health surveillance efforts such as this are 
vitally important to the health and well-being of former, current.and future employees of 
the Rocky Flats Plant. If you have any questions please feel free to contact me at (303) 
966-5297.
T. J/Ziegler4̂
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